** Shares of Shanghai Junshi Biosciences 1877.HK drop 9.8% to HK$25.85, on course to snap four straight session of gains
** Shanghai-listed stock 688180.SS falls 2.7% to 37.60 yuan, on track for the biggest one-day pct decline since May 26, if losses hold
** The Chinese biopharmaceutical group plans to sell 41 million new H-shares to third-party investors, raising HK$1.04 billion ($132.51 million) for commercialising potential new-generation drugs and for investment in R&D technologies
** The new H-shares will be issued at HK$25.35 each, or 11.5% discount to Thursday's close of HK$28.65 per share
** Hong Kong's healthcare index .HSCIH and Hang Seng Biotech Index .HSHKBIO both climb 1.1%
** YTD, Hong Kong stock up 137.5%, Shanghai shares up 38.4%
($1 = 7.8487 Hong Kong dollars)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。